Nephrosis: Clinical Trials

7 trials for Nephrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown. 7 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Unknown 7
Phase 32Unknown 2

Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome
Rituximab Biosimilar ABP 798, Daratumumab - Nephrotic Syndrome
Phase 2UnknownIstituto Giannina Gaslini202023-03-012023-10-31
Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome
Rituximab, Mycophenolate Mofetil - Nephrotic Syndrome in Children
Phase 2UnknownChildren's Hospital of Chongqing Medical University462023-01-292024-04-19
Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Idiopathic Nephrotic Syndrome.
Rituximab Biosimilar - Nephrotic Syndrome Steroid-Dependent
Phase 2UnknownIstituto Giannina Gaslini1602020-10-152022-12-21
RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome
Rituximab, Prednisone - Minimal Change Nephrotic Syndrome (MCNS)
Phase 2UnknownAssistance Publique - Hôpitaux de Paris1482020-07-292021-07-13
Valproic Acid for Idiopathic Nephrotic Syndrome
Valproic Acid - Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis
Phase 2 / Phase 3UnknownUniversitair Ziekenhuis Brussel152016-10-012017-06-20
Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
Rituximab, conventional therapy, Mesenchymal stem cells - Renal Insufficiency, Chronic, Nephrotic Syndrome
Phase 2UnknownZhujiang Hospital1162016-08-012016-11-22
Rituximab Trial for Pediatric Nephrotic Syndrome
Rituximab, Placebo - Steroid Resistant Nephrotic Syndrome, Steroid Dependent Nephrotic Syndrome
Phase 2 / Phase 3UnknownSeoul National University Childrens Hospital882012-08-012012-10-29

Narrower conditions

Nephrotic Syndrome (5)  ·  Nephrosis, Lipoid (2)  ·  Glomerulosclerosis, Focal Segmental (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Female Urogenital Diseases (7)  ·  Female Urogenital Diseases and Pregnancy Complications (7)  ·  Kidney Diseases (7)  ·  Male Urogenital Diseases (7)  ·  Urogenital Diseases (7)  ·  Urologic Diseases (7)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Glomerulonephritis (1)  ·  Nephritis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)

Interventions

Rituximab (4)  ·  Mycophenolic Acid (1)  ·  Prednisone (1)  ·  Valproic Acid (1)  ·  daratumumab (1)

Sponsors

Istituto Giannina Gaslini (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Children's Hospital of Chongqing Medical University (1)  ·  Seoul National University Childrens Hospital (1)  ·  Universitair Ziekenhuis Brussel (1)  ·  Zhujiang Hospital (1)

Countries

China (2)  ·  Italy (2)  ·  Belgium (1)  ·  France (1)  ·  South Korea (1)

Top investigators

GianMarco Ghiggeri, MD (1)  ·  Gianmarco Ghiggeri, MD (1)  ·  Peter Janssens, MD (1)  ·  Tang Xun, doctor (1)

Results publications

PMID 39513526, PMID 33611671, PMID 34845071, PMID 37705972, PMID 39431468, PMID 40337980, PMID 41563842

NIH funding

2018 (1)